All News

The newest urology products and services from Astellas Pharma US, Inc., Ethicon Endo-Surgery, Inc., Poiesis Medical, and Verathon Inc.

Repeat surgery occurs two to three times as often after newer minimally invasive interventions for BPH compared with transurethral resection of the prostate.

Do urologists consider the possibility that conditions other than strictly urologic problems in men are causing or contributing to their symptoms? And how willing are urologists to coordinate with other physicians when patients' conditions suggest other care is needed?

J. Stuart Wolf, Jr, MD, chair of the AUA Practice Guidelines Committee, discusses how AUA ensures that guidelines are scientifically rigorous and timely, the value of clinical guidelines, and the challenge of disseminating and implementing them.

Every urology practice faces this situation eventually: a difficult employee who demands disproportionate time and attention from management.

Early adopters of health information technology have been creating electronic health records for over 10 years. With the creation of the Health Information Technology for Economic and Clinical Health (HITECH) Act and its incentives, the pace of clinical data accumulation is accelerating.

Nearly as many American men as women may suffer from interstitial cystitis/bladder pain syndrome (IC/BPS) symptoms. And more men may have IC/BPS symptoms than have chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) symptoms, new data suggest.

Photoselective vaporization of the prostate (PVP) and transurethral resection of the prostate (TURP) have no difference overall in intermediate-term functional outcomes for surgical treatment of lower urinary tract symptoms secondary to BPH.

The decisions by the men and women who are elected will determine whether physicians who treat Medicare are fairly reimbursed; whether the Independent Payment Advisory Board (IPAB) is allowed to continue; and even how government agencies, task forces, and advisory boards that make recommendations on specific testing and treatment protocols are allowed to function.

An interim analysis of a validation study suggests that urine prostate cancer antigen 3 (PCA3) levels and urine TMPRSS2:ERG (T2:ERG) have additive utility in predicting clinically significant prostate tumor volume, and their use together may enhance the selection and monitoring of candidates with low-volume/low-grade disease for active surveillance.

A robot-assisted laparoscopic radical prostatectomy costs 40% more than a retropubic radical prostatectomy, according to a review of hospital data from one state.

Higher costs without greater benefits means that robotic procedures are at risk of not being supported by efforts to control health care costs.

Experimenting with human prostate cancer cells and mice, cancer-imaging experts at Johns Hopkins University, Baltimore say they have developed a method for finding and killing malignant cells while sparing healthy ones.

A team of disease experts and health economists at Johns Hopkins University, Baltimore warns that steadily declining rates of U.S. infant male circumcision could add more than $4.4 billion in avoidable health care costs if rates over the next decade drop to levels now seen in Europe.

A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to physicians at Duke Cancer Institute, Durham, NC.

Screening for prostate cancer has significant drawbacks, but limited screening could be beneficial, according to an analysis of results from a large European study.

About 40% of urologists report symptoms of burnout, a recent national survey of more than 7,000 physicians finds.

PODCAST Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.

Two companies with products in the urology market have signed new distribution agreements.

Due to manufacturing issues, a formulation of the bladder cancer treatment bacillus Calmette-Guérin is currently unavailable from one manufacturer.

Men with prostate cancer in Texas may be driving more than three times farther than needed to obtain radiation oncology treatments when treated at a urology-owned radiation oncology practice versus other facilities, according to a recent study.

Robot-assisted radical prostatectomy appears to provide better functional results for incontinence and potency, according to the authors of a study from Turin, Italy.

Researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center in New York have successfully developed and tested a new prostate cancer screening method.

Fesoterodine fumarate (Toviaz) appears to reduce urge urinary incontinence in patients with overactive bladder who had a suboptimal response to tolterodine tartrate extended release (Detrol LA), according to a phase IV study.

The impact of the proposed Centers for Medicare & Medicaid Services payment cuts to radiation oncology could severely impact community-based cancer care across the country, according to a recent survey from the American Society for Radiation Oncology.

As a man's waistline grows, so can his experience with sexual dysfunction and frequent urination, report researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center, New York.

A team of scientists has discovered a key factor that drives chemotherapy resistance

Multidisciplinary care is associated with increased selection of active surveillance in men with low-risk prostate cancer, according to a recent study.